[go: up one dir, main page]

SG11201811368SA - Sleep improving agent - Google Patents

Sleep improving agent

Info

Publication number
SG11201811368SA
SG11201811368SA SG11201811368SA SG11201811368SA SG11201811368SA SG 11201811368S A SG11201811368S A SG 11201811368SA SG 11201811368S A SG11201811368S A SG 11201811368SA SG 11201811368S A SG11201811368S A SG 11201811368SA SG 11201811368S A SG11201811368S A SG 11201811368SA
Authority
SG
Singapore
Prior art keywords
improving agent
sleep improving
protein expression
heat shock
inducing agent
Prior art date
Application number
SG11201811368SA
Inventor
Kazunori Goto
Jun Nakahigashi
Atsuya Sato
Yosuke Hirayama
Moeri Horikoshi
Noriyuki Kouda
Syoichiro Inoue
Ikutaro Sato
Manami Kato
Original Assignee
Amino Up Chemical Co Ltd
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amino Up Chemical Co Ltd, Otsuka Pharma Co Ltd filed Critical Amino Up Chemical Co Ltd
Publication of SG11201811368SA publication Critical patent/SG11201811368SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/30—Other Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides a heat shock protein expression-inducing agent, more specifically, a heat shock 5 protein expression-inducing agent comprising a compound represented by formula (I): 0 H / -4 ... .s 7 ,.- R ' * N H N 0 wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof. 10
SG11201811368SA 2016-05-26 2017-05-26 Sleep improving agent SG11201811368SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016105477 2016-05-26
PCT/JP2017/019644 WO2017204321A1 (en) 2016-05-26 2017-05-26 Sleep improving agent

Publications (1)

Publication Number Publication Date
SG11201811368SA true SG11201811368SA (en) 2019-01-30

Family

ID=60412712

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201912843YA SG10201912843YA (en) 2016-05-26 2017-05-26 Sleep improving agent
SG11201811368SA SG11201811368SA (en) 2016-05-26 2017-05-26 Sleep improving agent

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201912843YA SG10201912843YA (en) 2016-05-26 2017-05-26 Sleep improving agent

Country Status (8)

Country Link
US (4) US20190201395A1 (en)
EP (1) EP3466427A4 (en)
JP (3) JP7381000B2 (en)
KR (3) KR20240155382A (en)
CN (2) CN109562110A (en)
SG (2) SG10201912843YA (en)
TW (1) TWI733817B (en)
WO (1) WO2017204321A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7381000B2 (en) 2016-05-26 2023-11-15 株式会社アミノアップ sleep improver
JP7020797B2 (en) * 2017-04-25 2022-02-16 キリンホールディングス株式会社 Composition for autonomic nervous regulation
KR102308505B1 (en) * 2021-02-09 2021-10-01 서울대학교산학협력단 COMPOSITION FOR TREATMENT OF SARCOPENIA OR OSTEOPOROSIS THROUGH THE MECHANISM OF PROMOTING MYOBLAST DIFFERENTIATION OR INHIBITING THE DIFFERENTIATION OF OSTEOCLAST COMPRISING Cyclo (L-phenylalanyl-L-proline)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202279B1 (en) * 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
EP1296671B1 (en) * 2000-06-26 2008-03-26 Warner-Lambert Company LLC Gabapentin analogues for sleep disorders
JP2003252896A (en) 2002-02-26 2003-09-10 Toyohashi University Of Technology Method for synthesizing cyclic peptides using high-temperature high-pressure water
AU2003233175A1 (en) * 2002-06-10 2003-12-22 Tel Aviv University Future Technology Development L.P. Bacterial strain, compositions derived therefrom and methods of using same for treating beta-amyloid peptide-associated deseases
WO2005023815A2 (en) * 2003-09-03 2005-03-17 Neuren Pharmaceuticals Limited Neuroprotective bicyclic compounds and methods for their use
US20100286415A1 (en) * 2007-05-29 2010-11-11 Osaka Bioscience Institute Sleep-improving agent
GB2488500B (en) * 2009-12-25 2013-04-24 Suntory Holdings Ltd Substances for use as anti-depressants or as a learning motivation improver
WO2012043808A1 (en) * 2010-10-01 2012-04-05 大塚製薬株式会社 Heat shock protein expression inducer
JP2013071902A (en) * 2011-09-27 2013-04-22 Ltt Bio-Pharma Co Ltd Heat shock protein expression inducer
WO2013049174A1 (en) * 2011-09-29 2013-04-04 Abbvie Inc. Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers
JP5877063B2 (en) * 2011-12-28 2016-03-02 花王株式会社 Coffee extract
SI3024463T1 (en) * 2013-07-25 2020-08-31 Neuren Pharmaceuticals Limited Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders
JP5690028B1 (en) 2014-06-20 2015-03-25 サントリーホールディングス株式会社 Uric acid level lowering agent
DE102014117246B4 (en) 2014-11-25 2018-11-15 Heraeus Deutschland GmbH & Co. KG Method for producing a substrate adapter, substrate adapter and method for contacting a semiconductor element
KR102019472B1 (en) * 2015-10-05 2019-09-06 주식회사 엘지화학 Battery module and battery pack including the same
JP7381000B2 (en) 2016-05-26 2023-11-15 株式会社アミノアップ sleep improver

Also Published As

Publication number Publication date
KR20230047198A (en) 2023-04-06
KR20240155382A (en) 2024-10-28
KR20190028663A (en) 2019-03-19
JP7381000B2 (en) 2023-11-15
CN109562110A (en) 2019-04-02
EP3466427A4 (en) 2020-02-05
TW201808292A (en) 2018-03-16
US20230017155A1 (en) 2023-01-19
SG10201912843YA (en) 2020-02-27
JP2022078217A (en) 2022-05-24
US20200246335A1 (en) 2020-08-06
US20250082631A1 (en) 2025-03-13
WO2017204321A1 (en) 2017-11-30
JPWO2017204321A1 (en) 2019-04-04
EP3466427A1 (en) 2019-04-10
JP2024161450A (en) 2024-11-19
US12186312B2 (en) 2025-01-07
TWI733817B (en) 2021-07-21
CN120168475A (en) 2025-06-20
KR102514031B1 (en) 2023-03-27
US11478473B2 (en) 2022-10-25
US20190201395A1 (en) 2019-07-04

Similar Documents

Publication Publication Date Title
PH12020500673A1 (en) Compounds
MY199630A (en) Pyrimidinium compounds and their mixtures for combating animal pests
MX389921B (en) PIPERIDINONE HERBICIDES.
BR112017006253A2 (en) new compounds
MA40301B1 (en) Indolecarboxamide compounds useful as kinase inhibitors
SG11201804121RA (en) Novel biphenyl compound or salt thereof
CL2016000581A1 (en) Bicyclic azol pesticides substituted by heterocycle.
MX2021011972A (en) 2-(phenyloxy or phenylthio)pyrimidine derivatives as herbicides.
MY180083A (en) Tetrahydropyrrolothiazine compounds
PH12014502211A1 (en) Alkyl phenyl sulfide derivative and pest control agent
EA201690019A1 (en) AMINOTRIASIN DERIVATIVE AND CONTAINING ITS PHARMACEUTICAL COMPOSITION
EA201691439A1 (en) Pyrimidiniloxibenzene derivatives as herbicides
MX2022008434A (en) Pyridazinone herbicides.
MX380421B (en) SUBSTITUTED PYRIMIDINYLOXY BENZENE HERBICIDAL COMPOUNDS.
EA201891409A1 (en) BENZAMIDE COMPOUNDS AND THEIR APPLICATION AS HERBICIDES
EA201990279A1 (en) HERBICIDAL COMPOSITIONS CONTAINING PHENYLPYRIMIDINES
AR095523A1 (en) PIRIDIN-4-ILO DERIVATIVES
SG11201903801YA (en) Pyridone compound as c-met inhibitor
MX388175B (en) THERAPEUTIC COMPOUNDS AND METHODS OF USING THEM
EA202090368A1 (en) LYSOPHOSPHATID ACID RECEPTOR COMPOUNDS 1 (LPAR1)
MY178881A (en) Novel aqueous composition
EA201991253A1 (en) BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS
EA201591915A1 (en) COMPOUNDS OF PHENOXYETHYL DIHYDRO-1H-IZOHINOLINA
EA201991241A1 (en) METHOD FOR PRODUCING METHOXYMETHYLPYRIDINE DICARBOXYLATE
PH12019502868A1 (en) Composition for injection